A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)
Condition: Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Intervention: Drug: Gaboxadol Sponsor: Ovid Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials